Light-chain cardiac amyloidosis: A multimodality approach

This is a preview of subscription content, access via your institution.

Figure 1
Figure 2
Figure 3


  1. 1.

    Van Dalen BM, Soliman OI, Vletter WB, ten Cate FJ, Geleijnse ML. Insight into left ventricular function from the time course of regional and global rotation by speckle tracking echocardiography. Echocardiography 2009;26:371-7.

    Article  Google Scholar 

  2. 2.

    Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99m Tc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195-201.

    Article  Google Scholar 

  3. 3.

    Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2015;132:1570-9.

    CAS  Article  Google Scholar 

Download references


Erick Alexanderson-Rosas, Mara Escudero-Salamanca, Jesus A Garcia-Diaz, Ricardo Alvarez-Santana, Roberto Cano-Zarate, Julio Mamani-Tito, Isabel Carvajal-Juarez, Nilda Espinola-Zavaleta have no disclosure to declare.

Author information



Corresponding author

Correspondence to Nilda Espinola-Zavaleta MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


No fundings.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Alexanderson-Rosas, E., Escudero-Salamanca, M., Garcia-Diaz, J.A. et al. Light-chain cardiac amyloidosis: A multimodality approach. J. Nucl. Cardiol. 27, 2432–2435 (2020).

Download citation